Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: rob I who wrote (685)	10/28/1997 10:14:00 PM
From: Bruce Rosen	Read Replies (1) \| Respond to of 7041

<< Zonagen has a 40% success rate for men with mild impotence (Hmm, I wish our stock was presented in a more positive light.).>> The article in my local paper said Vasomax was successful in 40% of men with moderate impotence, not mild. I don't think Viagra is twice as effective as Vasomax. Pfizer's test population was more mildly impotent than Zonagen's and their standards of success were easier to attain. This publicity is good but lost in the current market environment.